Renal hemodynamic response to erythropoietin-induced polycythemia in 5/6 nephrectomised rats is different from normal rats

Experimental Nephrology

Volumn 6, Issue 3, 1998, Pages 245-252

  Paixão, Ana D O ^a   Ferreira, Alice T ^a   Oshiro, Maria E M ^a   Razvickas, Clara V ^a   Boim, Mirian A ^a   Schor, Nestor ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chronic renal failure; Erythropoietin; Indomethacin; Spontaneously hypertensive rats

Indexed keywords

4 AMINOHIPPURIC ACID; INDOMETACIN; INULIN; PROSTAGLANDIN; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY PLASMA FLOW; MALE; MEAN ARTERIAL PRESSURE; NEPHRECTOMY; NONHUMAN; POLYCYTHEMIA; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VASODILATATION;

EID: 0031861759     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020529     Document Type: Article

References (39)

1. Eschbach JW, Abdulhadi MH, Browne JK: Recombinant human erythropoietin in anaemic patients with end-stage renal disease: Results of phase HI multicentre clinical trial. Ann Intern Med 1989;111:992-1000.
2. Stabile C, Amar M, Draibe SA, Abensur H, Gordan PA, Losekann A, Garcia WD: Entropoetina recombinante para o tratamento da anemia do paciente renal crônico em hemodiálise: Estudo multicêntrico brasileiro. J Bras Nefrol 1991;13:45-54.
3. Bennet WM: Side effects of erythropoietin therapy. Am J Kidney Dis 1991 :XVIII:84-86.
4. Garcia DL, Andersen S, Reenke HG, Brenner BM: Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. Proc Natl Acad Sci USA 1988;85:6142-6146.
5. Wilcox CS, Deng X, Doll AH, Snellen H, Welch W: Nitric oxide mediates renal vasodilatation during erythropoietin-induced polycythemia. Kidney Int 1993;44:430-435.
6. De Wardener HER, McSwiney R: Renal haemodynamics in primaiy polycythemia. Lancet 1951;ii:204-205.
7. Drummond KN, Vernier RL, Worthen RA, Good RA: The associated occurrence of the nephrotic syndrome and congenital heart disease. Pediatrics 1963;31:103-114.
8. Jong PE, Weening JJ, Donker AJM, van der Hem GK: The effect of phlebotomy on renal function and proteinuria in a patient with congenital heart cyanotic disease. Nephron 1983;33:225-226.
9. Myers BD, Deen WM, Robertson CR, Brenner BM: Dynamics of glomerular ultrafiltration in the rat. VIII. Effects of hematocrit. Circ Res 1975;36:425-435.
10. Heindereich S, Rahn K-H, Zidek W: Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int 1991;39:259-265.
11. Neusser M, Tepel M, Zidek W: Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells. Cardiovasc Res 1993;27:1233-1236.
12. Mené P, Simonson MS, Dunn MJ: Physiology of the mesangial cell. Physiol Rev 1989;69:1347-1424
13. Chanutin A, Ferris EB: Experimental renal insufficiency produced by partial nephrectomy. Arch Intern Med 1932;49:767-787.
14. Henry RJ, Cannan DC, Winkelman JW: Clinical Chemistry: Principles and Techniques. New York. Harper & Row, 1974, pp 423-435.
15. Schor N, Ichikawa I, Brenner BM: Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat. Kidney Int 1981;20:442-451.
16. Boim MA, Ajzea H, Ramos OL, Schor N: Glomerular hemodynamics and hormonal evaluation during starvation in rats. Kidney Int 1992;42:567-572.
17. Ichikawa I, Maddox DA, Cogan MC, Brenner BM: Dynamics of glomerular ultrafiltration in euvotemic Munich-Wistar rats. Renal Physiol 1978;1:121-131.
18. Vurek GG, Pegram SE: Fluorimetric method for the determination of nanogram quantities of inulin. .Ann Biochem 1966;16:409-419.
19. Viets JW, Deen HM, Troy JL, Brenner BM: Determination of serum protein concentration in nanoliter blood samples using fluorescamine or O-phthalaldeyde. Anal Biochem 1978;88:513-521.
20. Deen WM, Robertson CR, Brenner BM: A model of glomerular ultrafiltration in the rat. Am J Physiol 1972;223:F1178-F1183.
21. Deen WM, Troy JL, Robertson CR, Brenner BM: Dynamics of glomerular ultrafiltration in the rat. IV. Determination of the ultrafiitration coefficient J Clin Invest 1973;52:1500-1508.
22. Fuhr J, Kaczmarcztk J, Kruttgen CD: Eine einfache colorimetrische Methode zur Inulinbestimmung für Nierenclearanceuntersuchungen bei Stoffwechselgesunden und Diabetikern. Klin Wochenschr 1955;33:729-730.
23. Smith HW, Finkelstein N, Aliminosa L, Crawford B, Garber M: The renal clearances of substituted hippuric acid derivates and other aromatic acids in dog and man. J Clin Invest 1945;24:388-404.
24. Eggena P, Willsey P, Jamgotchian N, Truckenbrod L, Hu MS, Barret JD, Eggena MP, Clegg K, Nakhoul F, Lee DBN: Influence of recombinant human erythropoietin on blood pressure and tissue renin-angiotensin systems. Am J Physiol 1991;261:E642-E646.
25. Muntzel M, Hannedouche T, Lacour B, Drucke TB: Effect of erythropoietin on hematocrit and blood pressure in normotensive and hypertensive rats. J Am Soc Nephrol 1992;3:182-187.
26. Muntzel M, Hannedouche T, Lacour B, Drucke TB: Erythropoietin increases blood pressure in normotensive and hypertensive rats. Nephron 1993;65:601-604.
27. Remuzzi A, Puntorieri S, Brugntti B, Bertani T, Remuzzi G: Renoprotective effect of low iron diet and its consequence on glomerular hemodynamics. Kidney Int 1991;39:647-652.
28. Dworkin LD, Feiner HD, Parker M, Tolbert E: Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomised SHR. Kidney Int 1991;39:1112-1117.
29. Dworkin LD, Feiner HD: Glomerular injury in uninephrectomised spontaneously hypertensive rats: A consequence of glomerular capillary hypertension. J Clin Invest 1986;77:797-809.
30. Chatziantoniou C, Arendshorst WJ: Renal vascular reactivity to vasodilator prostaglandins in genetically hypertensive rats. Am J Physiol 1992;262:F124-F130.
31. Robertson CR, Deen WM, Troy JL, Brenner BM: Dynamics of glomerular ultrafiltration in the rat. III. Hemodynamics and autoregulation. Am J Physiol 1972;223:1191-1200.
32. Nashat FS, Scholefield FR, Tappin JW, Wilcox CS: The effects of changes in haematocrit on the intrarenal distribution of blood flow in the dog's kidney. J Physiol 1969;201:639-655.
33. Simchom S, Chien RYZ, Carlin RD, Fan F-C, Jan K-M, Chien S: Effects of blood viscosity on plasma renin activity and renal hemodynamics. Am J Physiol 1986;250:F40-F46.
34. Schor N, Brenner BM: Possible mechanism of prostaglandin-induced renal vasoconstriction in the rat. Hypertension 1981;3(suppl II):81-85.
35. Naruse M, Nakamura N, Naruse K, Kubo K, Kato M, Hagiwara H, Sugino N, Demura H: Plasma immunoreactive endothelin levels are increased in hemodialysis patients with hypertension following erythropoietin therapy. Hypertens Res 1992;15:11-16.
36. Buga GM, Gold ME, Fukuto JM, Ignarro LJ: Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 1991;17:187-193.
37. Frangos JA, Eskin GS, McIntire LV, Ives CL: Flow effects on prostacyclin production by cultured human endothelial cells. Science 1985;227:1477-1479.
38. + current in vascular endothelial cells. Nature 1988;331:168-170.
39. Harris RC, Akai Y, Yasuda T, Homma T: The role of physical forces in alterations of mesangial cell function. Kidney Int 1994;45:S17-S21.